|
|
Volumn 28, Issue 1, 2002, Pages 63-73
|
|
The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome
a
|
|
Author keywords
Antipsychotics; Depressive symptoms; Positive symptoms; Schizophrenia; Social function; Treatment recommendations; Work function
|
|
Indexed keywords
CLOZAPINE;
FLUPHENAZINE;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DEMOGRAPHY;
DOSE RESPONSE;
FEMALE;
FUNCTIONAL ASSESSMENT;
HOSPITAL PATIENT;
HUMAN;
INTERVIEW;
MAJOR CLINICAL STUDY;
MALE;
OUTCOMES RESEARCH;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SCHIZOIDISM;
SCHIZOPHRENIA;
SIDE EFFECT;
SOCIAL STATUS;
SYMPTOM;
WORK CAPACITY;
CLINICAL PATHWAY;
CROSS-SECTIONAL STUDY;
MIDDLE AGED;
PSYCHOLOGICAL ASPECT;
PSYCHOLOGICAL RATING SCALE;
PSYCHOLOGY;
PSYCHOSIS;
SOCIAL ADAPTATION;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
ANTIPSYCHOTIC AGENTS;
CRITICAL PATHWAYS;
CROSS-SECTIONAL STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOTIC DISORDERS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SOCIAL ADJUSTMENT;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0035988547
PISSN: 05867614
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.schbul.a006927 Document Type: Article |
|
Times cited : (38)
|
|
References (18)
|
